The Synthesis, Photophysical and Photobiological Properties and in vitro Structure-Activity Relationships of a Set of Silicon Phthalocyanine PDT Photosensitizers-Reference-Cited by-同舟云学术

The Synthesis, Photophysical and Photobiological Properties and in vitro Structure-Activity Relationships of a Set of Silicon Phthalocyanine PDT Photosensitizers

Published:1997-03 Issue:3 Volume:65 Page:581-586
ISSN:0031-8655
Container-title:Photochemistry and Photobiology
language:en
Short-container-title:Photochem Photobiol

Author:

Li Ying-Syi,Zaidi S. I. A.,Rodgers Michael A. J.,Mukhtar Hasan,Kenney Malcolm E.,Oleinick Nancy L.,He Jin,Larkin Hedy E.,Rihter Boris D.

Publisher

Wiley

Subject

Physical and Theoretical Chemistry,General Medicine,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1751-1097.1997.tb08609.x/fullpdf

Reference20 articles.

1. Properties and Applications of Photodynamic Therapy

2. HOW DOES PHOTODYNAMIC THERAPY WORK?

3. PRECLINICAL EXAMINATION OF FIRST and SECOND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY

4. BIOLOGICAL ACTIVITIES OF PHTHALOCYANINES-IX. PHOTOSENSITIZATION OFV–79 CHINESE HAMSTER CELLS ANDEMT–6 MOUSE MAMMARY TUMOR BY SELECTIVELY SULFONATED ZINC PHTHALOCYANINES

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Emissive Zn(II) Naphthalocyanines: Synthesis, Structural and Photophysical Characterization with Theory-Supported Insights towards Soluble Coordination Compounds with Visible and Near-Infrared Emission;International Journal of Molecular Sciences;2024-02-23

2. Photothermal Conversion Materials and Requirements for Ideal Photothermal Materials;Laser-triggered Nanobiomaterials for Inhibiting Tumor Growth;2024

3. Silicon Phthalocyanines as Anti‐infectious, Antioxidant, and Anticancer Agents;ChemistrySelect;2023-05-16

4. Nanostructured self-assemblies of photosensitive dyes: Green and efficient theranostic approaches;Green Chemical Engineering;2022-07

5. Targeted cancer phototherapy using phthalocyanine–anticancer drug conjugates;Dalton Transactions;2022